EDGAR Filing Documents for 0001654954-18-002052

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001654954-18-002052

Filing Date

2018-03-01

Accepted

2018-03-01 16:10:11

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	gtbp_s-3.htm	S-3	696087
2	OPINION ON LEGALITY	gtbp_ec5-1.htm	EX-5.1	33655
3	CONSENTS OF EXPERTS AND COUNSEL	gtbp_ex23-1.htm	EX-23.1	4462
4	IMAGE	gtbp_ec5-1000.jpg	GRAPHIC	12584
5	IMAGE	gtbp_ex23-1000.jpg	GRAPHIC	15928
	Complete submission text file	0001654954-18-002052.txt		775038

Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602

Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888

GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)